Abstracts - faqs.org

Abstracts

Law

Search abstracts:
Abstracts » Law

U.S. cocaine lord faces challenge; a buyer of medical cocaine wants the DEA to end a seller's longtime sales lock

Article Abstract:

Mallinckrodt has a monopoly of the legal cocaine business. The company has imported narcotics since 1898. Raw opium and cocaine were freely traded until the 1930s, when concerns about drug addiction led to treaties dealing with the drug trade. Roxane Laboratories would like to break Mallinckrodt's monopoly and the Drug Enforcement Administration must consider the public interest and preventing diversion in deciding whether Roxane can enter the market. The chief use of legal cocaine is as an anesthetic in nasal surgery.

Author: Cotts, Cynthia
Publisher: ALM Media, Inc.
Publication Name: The National Law Journal
Subject: Law
ISSN: 0162-7325
Year: 1996
Health aspects, Management, Cocaine, Mallinckrodt Inc., Roxane Laboratories Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


As manufacturers seek approval for more new pharmaceuticals, issues such as the 'learned intermediary' rule will emerge in litigation involving clinical trials

Article Abstract:

The 'learned intermediary' rule will become a legal issue in drug clinical trials lawsuits. Products liability uses this rule, but there have been few products liability cases for drug testing so far. The more that pharmaceuticals manufacturers bring out new drugs, the more likely it is that such lawsuits will ensue due to injuries of test subjects.

Author: Traynor, Michael
Publisher: ALM Media, Inc.
Publication Name: The National Law Journal
Subject: Law
ISSN: 0162-7325
Year: 1996
Product liability, Clinical trials, Products liability

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


N.J. high court scuttles learned-intermediary rule; companies directing ads to consumers have a duty to warn; case will affect Web ads

Article Abstract:

Perez v. Wyeth Laboratories, a New Jersey Supreme Court case, is discussed, and it ruled that a drug manufacturer had a duty to warn consumers directly of the foreseeable risks of taking a drug if about to market this drug to consumers.Internet promotion of prescription drugs is sure to be affected by this ruling.

Author: Gaffney, P. Terrence
Publisher: ALM Media, Inc.
Publication Name: The National Law Journal
Subject: Law
ISSN: 0162-7325
Year: 2000
New Jersey, Advertising, Failure to warn (Law)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Pharmaceutical industry, Drugs, Cases
Similar abstracts:
  • Abstracts: A confidence revealed; an in-house lawyer who discloses bias complaints may not be protected from reprisal under Title VII
  • Abstracts: Mentoring programs boost law firm loyalty; often, having a good role model is the most important factor in associate satisfaction
  • Abstracts: Goldfish cracker case upholds emerging claim; the 2d Circuit affirmed an injunction based solely on trade dress dilution, not confusion
  • Abstracts: Greater predictability may result in patent pools; as the Federal Circuit refines scope of biotech claims, use of collective rights becomes likely
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.